0.412
price up icon11.35%   0.042
pre-market  プレマーケット:  .58   0.168   +40.78%
loading
前日終値:
$0.37
開ける:
$0.37
24時間の取引高:
870.15K
Relative Volume:
4.30
時価総額:
$2.17M
収益:
-
当期純損益:
$-11.53M
株価収益率:
-0.0855
EPS:
-4.82
ネットキャッシュフロー:
$-11.12M
1週間 パフォーマンス:
+3.00%
1か月 パフォーマンス:
-24.95%
6か月 パフォーマンス:
-68.99%
1年 パフォーマンス:
-82.47%
1日の値動き範囲:
Value
$0.3619
$0.4599
1週間の範囲:
Value
$0.36
$0.4599
52週間の値動き範囲:
Value
$0.36
$3.305

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
名前
Processa Pharmaceuticals Inc
Name
セクター
Healthcare (1165)
Name
電話
443-776-3133
Name
住所
7380 COCA COLA DRIVE, HANOVER
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
PCSA's Discussions on Twitter

PCSA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.412 2.17M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-25 開始されました H.C. Wainwright Buy

Processa Pharmaceuticals Inc (PCSA) 最新ニュース

pulisher
Mar 28, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com

Mar 25, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart

Mar 11, 2025
pulisher
Mar 04, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

Processa Pharma Stock Price, Quotes and Forecasts - Benzinga

Feb 28, 2025
pulisher
Feb 21, 2025

The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl

Feb 21, 2025
pulisher
Feb 21, 2025

Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions

Feb 21, 2025
pulisher
Feb 21, 2025

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025
pulisher
Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025
pulisher
Feb 13, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 11, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price - Investing.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025
pulisher
Feb 03, 2025

Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 03, 2025
pulisher
Jan 31, 2025

Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals Raises $5M in Public Offering - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals director David Young buys $99,288 in stock - Investing.com India

Jan 30, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 30, 2025
pulisher
Jan 29, 2025

Processa Pharmaceuticals' chief business officer buys $34,691 in stock By Investing.com - Investing.com South Africa

Jan 29, 2025
pulisher
Jan 29, 2025

Processa Pharmaceuticals director David Young buys $99,288 in stock By Investing.com - Investing.com South Africa

Jan 29, 2025
pulisher
Jan 29, 2025

Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 By Investing.com - Investing.com UK

Jan 29, 2025
pulisher
Jan 28, 2025

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Ulcerated Necrobiosis Lipoidica Market to Reach New Heights - openPR

Jan 28, 2025
pulisher
Jan 28, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 By Investing.com - Investing.com Canada

Jan 28, 2025
pulisher
Jan 28, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN

Jan 28, 2025
pulisher
Jan 27, 2025

Processa CEO and Board Members Double Down: Major Insider Buying in Latest $5M Deal - StockTitan

Jan 27, 2025

Processa Pharmaceuticals Inc (PCSA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Processa Pharmaceuticals Inc (PCSA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Ng George K
Chief Executive Officer
Jan 27 '25
Buy
0.80
87,200
69,542
87,200
Young David
Pres. Research & Development
Jan 27 '25
Buy
0.80
124,500
99,289
205,405
Lin Patrick
Chief Business - Strategy Off
Jan 27 '25
Buy
0.80
43,500
34,691
43,500
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):